Matches in SemOpenAlex for { <https://semopenalex.org/work/W2604944758> ?p ?o ?g. }
- W2604944758 endingPage "34934" @default.
- W2604944758 startingPage "34923" @default.
- W2604944758 abstract "// Haiyong Wang 1 , Jingze Zhang 1 , Fang Shi 1 , Chenyue Zhang 2 , Qinghua Jiao 3 , Hui Zhu 1 1 Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong Cancer Hospital Affiliated to Shandong University, Shandong Academy of Medical Sciences, Jinan 250117, China 2 Department of Integrative Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China 3 Cancer Center, The Second Hospital of Shandong University, Shandong 250033, China Correspondence to: Haiyong Wang, email: wanghaiyong6688@126.com Hui Zhu, email: drzhuhui@163.com Keywords: small cell lung cancer, young, cancer specific survival, SEER Received: September 16, 2016 Accepted: March 24, 2017 Published: April 04, 2017 ABSTRACT It has been reported that younger patients with non-small cell lung cancer (NSCLC) tend to have a better prognosis. Yet, few studies have focused on the clinicopathological characteristics and prognosis of young small cell lung cancer (SCLC), especially for patients with age < 50. In our study, we used Surveillance, Epidemiology, and End Results (SEER) population-based data and identified 16503 patients with SCLC including 711 patients aged < 50, 3338 patients aged 50–59, 5937 patients aged 60–69, 4649 patients aged 70–79 and 1868 patients aged ≥ 80 between 2010 and 2013. The Kaplan-Meier methods was used to develop the survival curve, and the results showed that the SCLC patients with aged < 50 tended to a better over survival (OS) and cancer specific survival (CSS) (all, P < 0.001). In addition, Cox regression model was used to analyze survival prognosis factors and perform subgroup analysis. The results showed that age was an independent prognostic factor for CSS ( P < 0.001). Importantly, we found that for the patients with AJCC stage III subgroup, the age < 50 had apparent CSS benefit compared with any other age group (all, P < 0.01). Interestingly, for the patients with no surgery, radiation and no radiation subgroup, the age < 50 had no apparent CSS benefit only compared with age 50–59 (all, P > 0.05). In conclusion, our study demonstrated that the SCLC patients with aged < 50 tended had a better survival benefit, especially for patients with AJCC stage III." @default.
- W2604944758 created "2017-04-14" @default.
- W2604944758 creator A5001129223 @default.
- W2604944758 creator A5017134771 @default.
- W2604944758 creator A5032470217 @default.
- W2604944758 creator A5035501418 @default.
- W2604944758 creator A5039780030 @default.
- W2604944758 creator A5069047497 @default.
- W2604944758 date "2017-04-04" @default.
- W2604944758 modified "2023-10-17" @default.
- W2604944758 title "Better cancer specific survival in young small cell lung cancer patients especially with AJCC stage III" @default.
- W2604944758 cites W1554896841 @default.
- W2604944758 cites W158341068 @default.
- W2604944758 cites W1752740598 @default.
- W2604944758 cites W1792077078 @default.
- W2604944758 cites W1824988371 @default.
- W2604944758 cites W1851872955 @default.
- W2604944758 cites W1905406155 @default.
- W2604944758 cites W1969518277 @default.
- W2604944758 cites W1985213644 @default.
- W2604944758 cites W2017967967 @default.
- W2604944758 cites W2018743405 @default.
- W2604944758 cites W2046317081 @default.
- W2604944758 cites W2055494312 @default.
- W2604944758 cites W2057375284 @default.
- W2604944758 cites W2058408106 @default.
- W2604944758 cites W2062668422 @default.
- W2604944758 cites W2065188377 @default.
- W2604944758 cites W2072712595 @default.
- W2604944758 cites W2076643424 @default.
- W2604944758 cites W2076995418 @default.
- W2604944758 cites W2085757096 @default.
- W2604944758 cites W2100255788 @default.
- W2604944758 cites W2101751898 @default.
- W2604944758 cites W2120277401 @default.
- W2604944758 cites W2131664752 @default.
- W2604944758 cites W2144226338 @default.
- W2604944758 cites W2151312078 @default.
- W2604944758 cites W2154323253 @default.
- W2604944758 cites W2164118670 @default.
- W2604944758 cites W2167201822 @default.
- W2604944758 cites W2265731839 @default.
- W2604944758 cites W2337222149 @default.
- W2604944758 cites W2341745217 @default.
- W2604944758 cites W2413052695 @default.
- W2604944758 cites W2597872842 @default.
- W2604944758 cites W4242747250 @default.
- W2604944758 cites W4376453862 @default.
- W2604944758 doi "https://doi.org/10.18632/oncotarget.16823" @default.
- W2604944758 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5471022" @default.
- W2604944758 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28432275" @default.
- W2604944758 hasPublicationYear "2017" @default.
- W2604944758 type Work @default.
- W2604944758 sameAs 2604944758 @default.
- W2604944758 citedByCount "14" @default.
- W2604944758 countsByYear W26049447582018 @default.
- W2604944758 countsByYear W26049447582019 @default.
- W2604944758 countsByYear W26049447582020 @default.
- W2604944758 countsByYear W26049447582021 @default.
- W2604944758 countsByYear W26049447582022 @default.
- W2604944758 countsByYear W26049447582023 @default.
- W2604944758 crossrefType "journal-article" @default.
- W2604944758 hasAuthorship W2604944758A5001129223 @default.
- W2604944758 hasAuthorship W2604944758A5017134771 @default.
- W2604944758 hasAuthorship W2604944758A5032470217 @default.
- W2604944758 hasAuthorship W2604944758A5035501418 @default.
- W2604944758 hasAuthorship W2604944758A5039780030 @default.
- W2604944758 hasAuthorship W2604944758A5069047497 @default.
- W2604944758 hasBestOaLocation W26049447581 @default.
- W2604944758 hasConcept C107130276 @default.
- W2604944758 hasConcept C121608353 @default.
- W2604944758 hasConcept C126322002 @default.
- W2604944758 hasConcept C143998085 @default.
- W2604944758 hasConcept C146357865 @default.
- W2604944758 hasConcept C151730666 @default.
- W2604944758 hasConcept C2776256026 @default.
- W2604944758 hasConcept C71924100 @default.
- W2604944758 hasConcept C86803240 @default.
- W2604944758 hasConceptScore W2604944758C107130276 @default.
- W2604944758 hasConceptScore W2604944758C121608353 @default.
- W2604944758 hasConceptScore W2604944758C126322002 @default.
- W2604944758 hasConceptScore W2604944758C143998085 @default.
- W2604944758 hasConceptScore W2604944758C146357865 @default.
- W2604944758 hasConceptScore W2604944758C151730666 @default.
- W2604944758 hasConceptScore W2604944758C2776256026 @default.
- W2604944758 hasConceptScore W2604944758C71924100 @default.
- W2604944758 hasConceptScore W2604944758C86803240 @default.
- W2604944758 hasIssue "21" @default.
- W2604944758 hasLocation W26049447581 @default.
- W2604944758 hasLocation W26049447582 @default.
- W2604944758 hasLocation W26049447583 @default.
- W2604944758 hasLocation W26049447584 @default.
- W2604944758 hasOpenAccess W2604944758 @default.
- W2604944758 hasPrimaryLocation W26049447581 @default.
- W2604944758 hasRelatedWork W1967103478 @default.
- W2604944758 hasRelatedWork W2032912323 @default.
- W2604944758 hasRelatedWork W2082603334 @default.
- W2604944758 hasRelatedWork W2356105190 @default.